NovaBay Pharmaceuticals, Inc.
NBY
$1.02
$0.088.50%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.73% | -125.06% | 732.84% | 0.00% | 23.53% |
| Total Depreciation and Amortization | -7.89% | -30.91% | -42.11% | 3.26% | 2.22% |
| Total Amortization of Deferred Charges | 90.00% | -23.08% | 766.67% | -97.93% | -53.38% |
| Total Other Non-Cash Items | 2,075.00% | -99.39% | 858.62% | 64.20% | -139.07% |
| Change in Net Operating Assets | 38.75% | -181.63% | 482.53% | 127.13% | -4,588.89% |
| Cash from Operations | 38.96% | -130.26% | 1,102.57% | 52.86% | -255.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | 100.00% | -27.17% |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | 1,173.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 90.41% | -- | -- | 100.00% |
| Cash from Financing | -658.05% | 89.81% | -441.60% | -76.05% | 524.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.13% | -138.86% | 2,422.83% | -1,430.77% | 102.43% |